14th metabolomics and proteomics€¦ · the global metabolomics market was valued at $565 million...

Conference SecretariatConferenceseries.com

47 Churchfield Road, London, W3 6AY, UK, Direct: +1 (702) 508-5200 Ext: 8122, Tel: +1 (800) 216 6499Email: [email protected], [email protected]

https://world.metabolomicsconference.com/

Metabolomics Summit 2019

Metabolomics and ProteomicsOsaka, Japan March 28-29, 2019

14th International Conference on


Conference Highlights

This year, we’ll host the event in beautiful city Osaka, Japan.

come early and treat yourself to a weekend vacation before the event!

• Metabolomic profiling

• Metabolomics and Cancer Research

• Metabolomic Analysis

• Human Metabolomics

• Single Cell Metabolomics

• Mass Spectrometry based Metabolomics

• Urine Metabolomics

• Clinical Metabolomics & Lipidomics

• Plant & Environmental Metabolomics

• Metabolic Syndrome

• Metabolomics in Precision Medicine

• Frontiers of Metabolomics Research

• Metabolomic Devices

• Analytical Platforms in Metabolomics

• Metabolic Modelling

• Case Reports

• Proteomics from Discovery to Function

• Proteomics for Bioinformatics

• Protein Expression and Analysis

• Proteomics and its Medicinal Research



Summary:Metabolomics is an emerging field which combines strategies to identify and quantify cellular

metabolites using sophisticated analytical technologies with the application of statistical and multi-variant methods for information extraction and data interpretation. Metabolomics is the study of small metabolites. Metabolomics Conference deals with topics like Bioinformatics, proteomics, systems biology, Analytical Techniques like NMR, GC-MS, LC-MS and CE-MS, Lipidomics, Metabolic Modelling, Metabolic profiling, clinical metabolomics, Translational sciences, Mass spectrometry, Metabolomics Syndrome, HPLC and CE based metabolomics and more. Metabolomics - the new “omics” - is a dynamic and developing field, joining genomics, transcriptomics and proteomics in empowering an integrative frameworks science methodology to drug discovery and development. In spite of the fact that metabolomics is still at an early evolutionary stage it is conjecture that throughout the following decade the biopharma business will apply this innovation all the more generally in drug development and information.

‘The Future of Metabolomics’ gives fully fledged understanding into the compelling utilization of metabolomics all through drug discovery, preclinical development and clinical trials. The report also highlights the use of metabolomics in maximizing and sustaining revenues post-marketing and in the development of clinical diagnostics.

Importance & Scope:Metabolomics is now being extensively used in pharmaceutical and biotechnology industries for

biomarker and drug discovery; pharmaceutical and biotechnology industries are expected to grow at a high rate in coming years, which is expected to boost the growth of the market.

The National Institutes of Health said that they are to invest $14.3 million for metabolomics research, potentially investing more than $51.4 million over five years, to accelerate an emerging field of biomedical research known as metabolomics. As per National Center for Biotechnology Information. Metabolomics has matured over the past 10 years. Over 300 studies have been completed over the past 5 years.

Why Osaka, Japan ?Japan is the second largest Life science market in the world after USA, Occupying about 10%

of Market in each of the global drug and Medical devices market. According to Data monitor , the Japanese biotechnology market had a total revenue of $ 43.3 Billion in 2013 . By 2017, the market is expected to grow to $ 53.8 Billion.

The Japanese pharmaceutical market is the world’s second-largest, with 2013 sales estimated at $115 billion. Japan accounts for a little less than 10 percent of the global Pharma market, compared with 38.4 percent for the U.S. and 20.7 percent for Western Europe


Market Analysis


The Japanese market is a promising region for metabolomics companies, as a high amount of

metabolomics research is being conducted in the country.

Global Life science Market Share by Country

Why to attend ???Meet Your Target Market With recent business reports on Metabolomics making news which

manifests the tremendous growth in market value for metabolomics technology till 2019. Since metabolomics interrelated with omics sciences like Genomics, precision Medicine, Proteomics, Lipidomics, Fluxomics and Transcriptomics, it would be a great opportunity for companies dealing with Analytical instruments useful in these fields. Also many upcoming students and researchers can benefit themselves by participating world class International workshops, symposia during the conference which will be conducted by experts in the respective fields.

Major Metabolomics Related Associations around the Globe :Metabolomics Society American association for the advancement of scienceAmerican association for clinical chemistry American association for cancer researchAmerican association of pharmaceutical scientists Association for Consumer Research (ACR)American cancer society Bioinformatics society of India Nutrigenomics Organization



The British Society for Genetic MedicineThe Genetics SocietyNetherlands metabolomics centerThe Australian biotechnology associationHuman Proteome OrganizationIndiana Proteomics ConsortiumProteome SocietyEuropean federation of biotechnologyAustralasian Proteomics SocietyClinical Genetics Society

Major Metabolomics Related Research Units in Osaka, Japan :NERI - National University of Osaka, JapanOsaka, Japan Centre for Environmental Life Sciences EngineeringDuke-NUS Medical SchoolOsaka, Japan-MIT Alliance for Research and TechnologyGenome Institute of Osaka, Japan (GIS) - A StarOsaka, Japan National Academy of ScienceThe National Research Foundation (NRF), Osaka, JapanNanyang Technological UniversityJames Cook University Osaka, JapanGerman Institute of Science and Technology

Target Audience: Directors/Managers & Business Delegates, Director of Laboratories, Universities, Industries,

Investigators, PostDoctoral Fellows, Research and Diagnostic Laboratories, Clinical Fellows, Students, Biomedical Research companies.

Rise in the number of clinical trials, toxicological studies, and health awareness for nutritional products, rapid growth of metabolomics data analysis software and solutions, and use of metabolomics as diagnostics tool for biomarker screening of diseases is expected to propel the growth of this market.



Glance at Market of Metabolomics:The market is mainly driven by the increasing research funding for metabolomics from governments

and private investors, growing demand for personalized medicine in the U.S. and Europe, and the increasing need for toxicology testing. However, low adoption rates and data complexity inhibits the growth of the metabolomics market to a certain extent. Metabolomics science is used extensively in biomarker discovery and drug assessment. Thus, the rapid growth experienced by pharmaceutical and biotechnology industries is assisting the growth of the metabolomics market.

In 2013, North America was the market leader with a share of ~42% of the global market, followed by Europe with a share of ~38%. The presence of a large number of analytical equipment manufacturers has contributed significantly to the North American and European metabolomics market. However, the Asia-Pacific region represents a significant growth opportunity for the metabolomics market during the forecast period of 2014 to 2019. The APAC market is expected to grow at a CAGR of 23% during the forecast period. The growth in this market is driven by the growing pharmaceutical and biotechnology industries.

The global metabolomics market was valued at $565 million in 2014 and is expected to grow at a CAGR of 30% from 2014 to 2019.

Statistics which shows growth in importance of Metabolomics :Metabolomics Market Worth $2,100 Million by 2019 - New Report by Markets and Markets.Statistics of Industries Associated with Metabolomics :North America was the market leader with a share of ~42% of the global market, followed by

Europe with a share of ~38%. The presence of a large number of analytical equipment manufacturers has contributed significantly to the North American and European metabolomics market. However,



the Asia-Pacific region represents a significant growth opportunity for the metabolomics market during the forecast period of 2014 to 2019. The APAC market is expected to grow at a CAGR of 23% during the forecast period. The growth in this market is driven by the growing pharmaceutical and biotechnology industries.

The major players in the metabolomics market include Thermo Fisher Scientific (U.S.), Metabolon, Inc. (U.S.), Danaher Corporation (U.S.), Shimadzu Corporation (Japan), Waters Corporation (U.S.), Agilent Technologies (U.S.), and Bruker Corporation (U.S.).

Fund Allotment towards Metabolomics Research :The National Institutes of Health has provided tens of millions of dollars in new funding

to support three new Comprehensive Metabolomics Centers at Mayo Clinic, the University of Kentucky, and the University of Florida.

These three centers will receive an estimated $9 million to $10 million each over the next five years to create resources and initiate research programs that will ramp up the national metabolomics science capabilities.




NIH provided $14.3 million to fund the launch of three other metabolomics resource centers at the University of Michigan, the Research Triangle Institute, and the University of California, Davis.

• Michigan Regional Comprehensive Metabolomics Resource Core (MRC2) • NIH West Coast Metabolomics Center at UC Davis• Southeast Center for Integrated Metabolomics (SECIM) • Metabolomics Core at Mayo Clinic • Research Center for Stable Isotope Resolved MetabolomicsFunding to UC San Diego for this project is $6 million over five years, part of a total

investment by the NIH of $51.4 for the metabolomics project. The awards are supported by the NIH Common Fund.

Metabolomic Diagnostics is engaged in a study called IMPROvED, which has received €6m in European FP7 funding.

Mayo Clinic is one of six new federally-funded Comprehensive Metabolomics centres to support medical research on metabolomics — the study, at the cellular level, of how molecules are metabolized in the body. The award from the National Institutes of Health (NIH) is for $8.8 million over five years.


Metabolomics Previous Sponsors and Exhibitors



Glimpses of Metabolomics Congress


About OsakaOsaka is the capital city of Japan and it is the world’s most populous metropolis with its stunning,

stimulating and seductive atmosphere. It is one of Japan’s 47 prefectures, consisting of 23 central city wards and multiple cities, towns and villages west of the city centre. Before 1868, Osaka earlier known as Edo, was a small castle town in the 16th century. It became Japan’s political centre in 1603 under Tokugawa Ieyasu then, after Emperor Meiji moved his seat to the city from the old capital of Kyoto in 1868, it became the official capital. The city’s history can be appreciated in regions like Asakusa, and in many brilliant museums, historic temples and gardens.

Today, it offers a curious choice of shopping, entertainment, museums, galleries, shrines and temples for its visitors. Swaggering a stridency of contrasts, Japan’s megalopolis is by turns electrifying, enthralling and exhausting. It is a city of a dozen different characters; therefore visitors can pretty much choose their Osaka based on whether they want frenzied and ear-splitting or serene zen-like calm; spiralling skyscrapers or tiny veiled backstreet reliquaries; the elastic and neon of the love inns or the tatami mat simplicity of traditional Ryokans. Osaka offers an implausible volume to take in with its barrage of sights and sensations. It also offers a number of attractive green spaces in the city centre and within relatively short train rides at its suburbs.

Osaka has the leading metropolitan economy in the world and is a major international finance centre. It houses the headquarters of several of the world’s largest investment banks and insurance companies, and serves as a hub for Japan’s transportation, publishing, electronics and broadcasting industries. Public transportation within Osaka is ruled by an widespread network of clean and efficient trains and subways run by a variety of operators, with buses, monorails and trams playing a secondary feeder role.


Email: [email protected], [email protected]

The field of Metabolomics and Proteomics is growing rapidly and its development is making tremendous impacts in Food and Beverages Industry. The importance and significance can be

gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors.


• Opportunity to attend the presentations delivered by eminent scientists from all over the world

• Selected contributions will be published in following Conference Series llc Ltd.Journals• Metabolomics: Open Access• Journal of Computer Science & Systems Biology

• Participation in sessions on specific topics on which the conference is expected to achieve progress

• Global networking: In transferring and exchanging Ideas

• Conference brings together Scientific Researchers, Food and Beverages Industrialists

VenueOsaka, Japan


Important DatesAbstract submission opens: August 01, 2018Registration opens: August 10, 2018Early bird registration: August 31, 2018On spot registration: March 28, 2019

Asakusa and the Sensō-ji Temple

The Kabuki-za Theatre

Osaka National Museum

The Imperial Palace Osaka DisneySea

Ueno Park and Zoo

The Meiji Shrine

National Museum of Western Art

Best Tourist Destinations in Osaka

14th metabolomics and proteomics€¦ · the global metabolomics market was valued at $565 million...

Documents